All In Biotech

Free tool

FAERS Monitor: Prismasol B22gk 2/0 In Plastic Container

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021703 or its brand name (Prismasol B22gk 2/0 In Plastic Container, Calcium Chloride, Dextrose, Lactic Acid, Magnesium Chloride, Potassium Chloride, Sodium Bicarbonate, Sodium Chloride). Reports on generic versions are filed under their own applications.

Reports

63

Serious

51

81% of reports

Hospitalization

8

Death reported

20

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • haemorrhage17
  • death14
  • hypotension8
  • cardiac arrest6
  • device issue6
  • acute kidney injury4
  • blood pressure decreased4
  • haemodialysis complication4
  • anaemia3
  • haemoglobin decreased3
  • multi-organ failure3
  • renal failure3
  • respiratory failure3
  • somnolence3
  • thrombocytopenia3

Reports by year received

View as table
YearReports
20101
20121
20132
201412
20153
201610
20174
20182
20194
202015
20215
20222
20251
20261

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,096 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
haemodialysis complicationSignal48052.83081.824,075
multi-organ failureSignal357.919.2116
haemorrhageSignal1754.336.2841
cardiac arrestSignal624.311.3112
device issueSignal622.310.4102
blood pressure decreasedSignal420.17.855
respiratory failureSignal313.74.624
hypotensionSignal813.37.080
haemoglobin decreasedSignal39.83.216
thrombocytopeniaSignal39.03.014
acute kidney injurySignal48.73.420
renal failureSignal37.52.511
deathSignal145.43.448
anaemiaSignal35.31.77
somnolenceSignal35.01.66

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.